Morning Overview on MSN
Ozempic-style drugs may help the heart recover after a heart attack, a trial found
Researchers at University College London have identified a specific mechanism by which GLP-1 receptor agonists, the drug ...
Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...
Morning Overview on MSN
Some common viruses may sharply raise the risk of heart attack and stroke, a study found
A growing body of research links several widespread viral infections to sharp, short-term spikes in heart attack and stroke ...
A genome-wide association study links genetic variants to reduced coronary flow reserve, implicating the nuclear factor kappa B pathway in coronary microvascular disease.
Over the last 33 years, acting on modifiable risk factors has helped to prevent deaths caused by ischemic heart disease, new ...
Managing risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.
VahatiCor CEO Harry Rowland explains how the nitinol A-Flux reducer implant is designed to treat coronary microvascular ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. The global burden, secular ...
The buildup of fats, cholesterol, calcium, and immune cells within the blood vessel can lead to the narrowing or even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results